NanoString Technologies, Inc.
NanoString Technologies develops and sells technology for genomics and proteomics. They offer nCounter Analysis System, including Prep Station and Digital Analyzer. The company also offers nSolver Analysis Software, custom CodeSets, Master Kits, cartridges, and reagents. Prosigna in vitro diagnostic kits are also available. NanoString is developing GeoMx DSP system for spatial biology. The company collaborates with various organizations to develop new products and therapies.
Overview
Sector
Medical Instruments & Supplies
Strengths
- Price to book ratio (0.11) is lower than the sector mean (3.86).
Weaknesses
- With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
- The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
- The company have lower returns than the sector in which it operates. ROIC (0.00%) is significantly lower than the sector mean (8.23%).
- EV/EBITDA (100.00) is significantly higher than the sector mean (47.53).
- EV/EBIT (100.00) is significantly higher than the sector mean.
- The Price to Free Cash Flow ratio (100.00) is significantly higher than the sector mean.
- EBITDA Margin (0.00%) appears relatively low.
Key Financial Data
| Indicator | Value |
|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | -% |
| Net Debt/EBITDA | 100.0 |